Study guide

8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

Key Takeaways Explain This Topic AI

Record the highest valid aortic-jet velocity with well-aligned CW Doppler from multiple acoustic windows and document the window; never average lower, misaligned peaks.

Trace the dense CW envelope for mean gradient, recognizing that mean gradient averages instantaneous 4V² values and is not 4 times the square of mean velocity.

Continuity-equation AVA depends on a matched LVOT diameter and PW VTI plus a complete AV CW VTI; LVOT diameter error is squared in the area calculation.

Classify discordance by gradient, stroke-volume index, and LVEF only after checking Doppler alignment, LVOT measurement, rhythm, blood pressure, and high- or low-flow causes.

Severe AS is an integrated conclusion using hemodynamics, valve anatomy, flow, ventricular response, symptoms, and appropriate adjunct imaging—not one threshold in isolation.

Last updated: July 2026

Build the hemodynamic dataset in the right order

CCI task C2 is to assess aortic stenosis (AS). Begin with valve morphology and color localization, then acquire LVOT PW Doppler and aortic-jet CW Doppler. The primary ASE/EACVI hemodynamic measures are peak aortic-jet velocity, mean transvalvular gradient, and continuity-equation aortic valve area (AVA). They answer related but different questions and are flow dependent in different ways. No single number should overrule obviously contradictory anatomy, flow, or acquisition quality. Record heart rate, rhythm, and blood pressure because they shape the hemodynamic context.

Align CW as parallel as possible to the jet. Interrogate apical, right-parasternal, suprasternal, and other appropriate windows with a dedicated small-footprint nonimaging transducer when needed. Use the highest valid dense velocity , not an average across windows, and document where it was obtained. A small angle error underestimates velocity and, because pressure uses velocity squared, causes a larger gradient error. Exclude mitral regurgitation, dynamic LVOT obstruction, noise, and fine linear transit-time artifact before tracing.

Trace the outer edge of the dense CW envelope through systole. The simplified Bernoulli equation gives an instantaneous gradient:

ΔP = 4V²

At 4.0 m/s, the peak instantaneous gradient is 64 mmHg. The machine calculates mean gradient by averaging all instantaneous 4V² values during ejection. It is incorrect to square the mean velocity. Check that the trace follows the dense modal border rather than faint feathering and that an irregular rhythm is averaged according to laboratory and disease-specific guidance.

  • Parameter Standard severe-pattern marker Acquisition safeguard
  • Peak AV velocity 4.0 m/s or greater Highest valid multiwindow CW signal
  • Mean gradient 40 mmHg or greater Complete dense envelope; trace instantaneous gradients
  • AVA 1.0 cm² or less Matched LVOT diameter and PW site; complete AV VTI
  • Indexed AVA 0.6 cm²/m² or less Use body-size context, especially small adults
  • Dimensionless index 0.25 or less LVOT VTI divided by AV VTI from representative beats

These are standard guideline markers, not five independent verdicts. Cutoffs are not perfectly mathematically concordant, and high or low flow can move velocity and gradient without an equivalent change in anatomic valve narrowing.

Protect the continuity equation from compounded error

The continuity principle assumes stroke volume in the LVOT equals flow through the stenotic valve:

AVA = CSA(LVOT) × VTI(LVOT) / VTI(AV)

Measure LVOT diameter inner edge to inner edge in a zoomed parasternal long-axis view during mid-systole at the same anatomic level represented by PW sampling. Calculate circular area as π(D/2)² . Because diameter is squared, a 10% diameter error produces about a 21% area error. The true LVOT is often elliptical, so a circular assumption can underestimate area and stroke volume. Do not move the diameter calipers simply to make AVA agree with gradient.

From an apical approach, place a 3–5 mm PW gate on the LV side of the valve just proximal to flow acceleration. Move it slowly apically until the envelope is smooth and narrow; broadening means the gate is too close to accelerated flow. Trace the dense modal LVOT VTI and use corresponding beats for AV VTI when rhythm varies. For D = 2.0 cm, LVOT VTI = 20 cm, and AV VTI = 80 cm, CSA is 3.14 cm² and AVA is about 0.79 cm² . That calculation suggests a small effective orifice, but it still requires concordance review.

The dimensionless index equals LVOT VTI divided by AV VTI and avoids the LVOT diameter term. It is useful when diameter is uncertain, but it does not rescue a contaminated LVOT sample or misaligned AV envelope. Direct TTE planimetry is limited by calcific shadowing and by difficulty locating the smallest cusp-tip orifice; effective Doppler orifice area is not identical to anatomic planimetered area.

Resolve discordance before assigning severity

A concordant high-gradient severe pattern typically has Vmax at least 4.0 m/s or mean gradient at least 40 mmHg with a small AVA and supportive calcified restricted anatomy. Even then, check for reversible high-flow states such as anemia, sepsis, hyperthyroidism, significant regurgitation, or shunt. A high gradient is not interpreted in a vacuum.

When AVA is 1.0 cm² or less but velocity and mean gradient are below the severe-pattern thresholds, first repeat quality control: Doppler alignment and all windows, LVOT diameter and PW site, rhythm averaging, BP, body size, and arithmetic. Then calculate stroke volume index (SVi) and review LVEF. The 2017 ASE/EACVI framework defines low flow using SVi below 35 mL/m² and separates reduced EF from preserved EF.

Classic low-flow, low-gradient AS has reduced LVEF. Under an authorized, medically supervised low-dose dobutamine protocol, changes in flow, velocity, gradient, AVA, and contractile reserve can help distinguish truly severe from pseudosevere stenosis. Paradoxical low-flow, low-gradient AS has preserved EF, often with a small hypertrophied LV; measurement error and severe hypertension must be excluded, and CT valve calcium may add evidence. Normal-flow, low-gradient discordance commonly reflects moderate disease or cutoff/measurement inconsistency but still requires clinical review and follow-up.

Report the acquired facts and limitations: valve morphology and calcification, maximum-velocity window, Vmax, mean gradient, LVOT diameter and VTI, AV VTI, AVA, dimensionless index, SVi, LVEF, BP, rhythm, and associated LV or aortic findings. The interpreting clinician integrates symptoms and adjunct testing. Precision means making every input defensible—not making one threshold decisive.